New Drugs for Rheumatoid Arthritis: What's in the Pipeline

Links shared publicly online about this topic.

  • 994
    total visits

New Drugs for Rheumatoid Arthritis: What's in the Pipeline

webmd.com

The latest on research and development about oral biologics to treat rheumatoid arthritis.

View full resource at webmd.com

Tags: Arthritis, Rheumatoid Arthritis, Drug

  • Share

Most Recently Shared on July 26, 2010 at 6:13 pm By:

totalbodytweets Dr. Jason Conviser

New Drugs for Rheumatoid Arthritis: What's in the Pipeline: The latest on research and development about oral biol... http://bit.ly/aVhjZO

2 years ago...

Why Pfizer’s Biggest Experimental Drug Got A Name Change - Matthew Herper - The Medicine Show - Forbes

blogs.forbes.com — “Earlier this week Pfizer released a neat-o interactive version of its pipeline of experimental drugs, including updates on which have moved into new clinical trials. One surprise: the generic name for the company's new JAK3 inhibitor for rheumatoid arthritis had changed. Once known as tasocitinib, it will henceforth be known as [...]View full resource at blogs.forbes.com

  • View Related
  • Share

Most Recently Shared on March 3, 2011 at 5:31 am By:

Drugs_Devices Drugs and Devices OW OW Health

Why Pfizer's Biggest Experimental Drug Got A Name Change: Why one of Pfizer's experimental medicines had i... http://bit.ly/fCvDg8 #drug

1 year ago...

Conquering Arthritis: New Rheumatoid Arthritis Medications: The Life Threatening FDA Drug Approval Process

rheumatoidarthritistreatmentarthritis.blogspot.com — “Conquering Arthritis: New Rheumatoid Arthritis Medications: The Life Threatening FDA Drug Approval ProcessView full resource at rheumatoidarthritistreatmentarthritis.blogspot.com

  • View Related
  • Share

Most Recently Shared on February 10, 2011 at 5:25 am By:

Rheumatoid Barbara Allan Patient Expert

New Article: New Rheumatoid Arthritis Medications: The Life Threatening FDA Drug Approval Process: http://fd.ag/2PTY What do you think?

1 year ago...

Medical News: ACR: New RA Drug Tops Meeting Agenda - in Meeting Coverage, ACR from MedPage Today

medpagetoday.com — “ATLANTA -- Rheumatologists will get a much-anticipated look at phase III results for a novel rheumatoid arthritis drug with blockbuster potential during what promises to be a busy week at the AmericanView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on November 5, 2010 at 9:07 pm By:

PattyGrace Patricia Grace Eldercare Expert

ACR: New RA Drug Tops Meeting Agenda: ATLANTA (MedPage Today) -- Rheumatologists will get a much-anticipated loo... http://bit.ly/bzKW42

1 year ago...

Advertisement